Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Masaru, Kumagai"'
Autor:
Masaru Kumagai, Atsunori Tsuchiya, Yuan Yang, Nobutaka Takeda, Kazuki Natsui, Yui Natusi, Kei Tomiyoshi, Fusako Yamazaki, Yohei Koseki, Hiroki Shinchi, Naoko Imawaka, Ryo Ukekawa, Takahiro Nishibu, Hiroyuki Abe, Takako Sasaki, Koji Ueda, Shuji Terai
Publikováno v:
FEBS Open Bio, Vol 14, Iss 8, Pp 1264-1276 (2024)
Chronic liver injury leads to decreased liver function and increased fibrosis. Fibrosis is not only associated with the development of portal hypertension and carcinogenesis, but with the occurrence of events and a poor prognosis, highlighting the im
Externí odkaz:
https://doaj.org/article/9d21237a27c448d1b35fe7dc75c3bf3f
Autor:
Satoko Motegi, Atsunori Tsuchiya, Takahiro Iwasawa, Takeki Sato, Masaru Kumagai, Kazuki Natsui, Shunsuke Nojiri, Masahiro Ogawa, Suguru Takeuchi, Yosiki Sakai, Shigeru Miyagawa, Yoshiki Sawa, Shuji Terai
Publikováno v:
Inflammation and Regeneration, Vol 42, Iss 1, Pp 1-14 (2022)
Abstract Background ONO-1301 is a novel long-lasting prostaglandin (PG) I2 mimetic with inhibitory activity on thromboxane (TX) A2 synthase. This drug can also induce endogenous prostaglandin (PG)I2 and PGE2 levels. Furthermore, ONO-1301 acts as a cy
Externí odkaz:
https://doaj.org/article/a45b9fb5974546048ca45f89786dbcdc
Autor:
Takahiro Iwasawa, Shunsuke Nojiri, Atsunori Tsuchiya, Suguru Takeuchi, Takayuki Watanabe, Masahiro Ogawa, Satoko Motegi, Takeki Sato, Masaru Kumagai, Taiki Nakaya, Katsuya Ohbuchi, Miwa Nahata, Naoki Fujitsuka, Masaaki Takamura, Shuji Terai
Publikováno v:
Regenerative Therapy, Vol 18, Iss , Pp 231-241 (2021)
Background: Liver cirrhosis is an end-stage multiple liver disease. Mesenchymal stem cells (MSCs) are an attractive cell source for reducing liver damage and regressing fibrosis; additional therapies accompanying MSCs can potentially enhance their th
Externí odkaz:
https://doaj.org/article/1656415cb147473db64c3acf63d3718d
Autor:
Shunsuke Nojiri, Atsunori Tsuchiya, Kazuki Natsui, Suguru Takeuchi, Takayuki Watanabe, Yuichi Kojima, Yusuke Watanabe, Hiroteru Kamimura, Masahiro Ogawa, Satoko Motegi, Takahiro Iwasawa, Takeki Sato, Masaru Kumagai, Yui Ishii, Tomomi Kitayama, Yu-Tung Li, Yuya Ouchi, Takashi Shimbo, Masaaki Takamura, Katsuto Tamai, Shuji Terai
Publikováno v:
Inflammation and Regeneration, Vol 41, Iss 1, Pp 1-15 (2021)
Abstract The liver has a high regenerative ability and can induce spontaneous regression of fibrosis when early liver damage occurs; however, these abilities are lost when chronic liver damage results in decompensated cirrhosis. Cell therapies, such
Externí odkaz:
https://doaj.org/article/b12286f4bc7841a399f9b7b2e8ece5b3
Autor:
Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, Masaru Kumagai, Takeki Sato, Satoko Motegi, Yui Ishii, Youhei Koseki, Kei Tomiyoshi, Kazuki Natsui, Nobutaka Takeda, Yuki Yoshida, Fusako Yamazaki, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai
Publikováno v:
Inflammation and Regeneration, Vol 40, Iss 1, Pp 1-6 (2020)
Abstract The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide pandemic. The spread of the virus has had global effects such as activ
Externí odkaz:
https://doaj.org/article/08e8189e496c4fbf8d3fd3404291ec0a
Autor:
Toru, Setsu, Takeshi, Yokoo, Takeki, Sato, Masaru, Kumagai, Satoko, Motegi, Yuzo, Kawata, Kohei, Ogawa, Ken-Ichi, Mizuno, Shuji, Terai
Publikováno v:
Internal Medicine. 61:1959-1962
Mesenteric hematoma is an uncommon condition caused by focal bleeding in the mesenteric vessels. Hematomas are related to trauma, pancreatitis, arteriopathy, and the use of antithrombotic agents. Although hematomas cause intestinal stenosis by compre
Autor:
Masaru Kumagai, Suguru Takeuchi, Takahiro Iwasawa, Yuichi Kojima, Takashi Shimbo, Tomomi Kitayama, Yusuke Watanabe, Yui Ishii, Shuji Terai, Masaaki Takamura, Takeki Sato, Kazuki Natsui, Yuya Ouchi, Masahiro Ogawa, Yu-Tung Li, Hiroteru Kamimura, Atsunori Tsuchiya, Shunsuke Nojiri, Katsuto Tamai, Takayuki Watanabe, Satoko Motegi
Publikováno v:
Inflammation and Regeneration, Vol 41, Iss 1, Pp 1-15 (2021)
Inflammation and Regeneration
Inflammation and Regeneration
The liver has a high regenerative ability and can induce spontaneous regression of fibrosis when early liver damage occurs; however, these abilities are lost when chronic liver damage results in decompensated cirrhosis. Cell therapies, such as mesenc
Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma
Autor:
Masaru Kumagai, Shunsuke Nojiri, Atsunori Tsuchiya, Shuji Terai, Satoko Motegi, Takeki Sato, Suguru Takeuchi, Takashi Owaki, Yusuke Watanabe, Takahiro Iwasawa, Masahiro Ogawa, Yuzo Kawata, Hiroteru Kamimura
Publikováno v:
Biochemical and Biophysical Research Communications. 566:36-44
The number of patients with non-alcoholic steatohepatitis (NASH) and inflammatory bowel disease (IBD) is increasing. This study elucidates the effect of both NASH and IBD on hepatocellular carcinoma (HCC) using a mouse model combining NASH and IBD. T
Autor:
Masaaki Takamura, Naoki Fujitsuka, Masahiro Ogawa, Taiki Nakaya, Masaru Kumagai, Shuji Terai, Shunsuke Nojiri, Suguru Takeuchi, Takeki Sato, Katsuya Ohbuchi, Takayuki Watanabe, Atsunori Tsuchiya, Satoko Motegi, Miwa Nahata, Takahiro Iwasawa
Publikováno v:
Regenerative Therapy
Regenerative Therapy, Vol 18, Iss, Pp 231-241 (2021)
Regenerative Therapy, Vol 18, Iss, Pp 231-241 (2021)
Background Liver cirrhosis is an end-stage multiple liver disease. Mesenchymal stem cells (MSCs) are an attractive cell source for reducing liver damage and regressing fibrosis; additional therapies accompanying MSCs can potentially enhance their the
Publikováno v:
半田山地理考古. 9:111-117